BRPI0412243A - uso de cd164 solúvel em distúrbios inflamatórios e/ou autoimunes - Google Patents

uso de cd164 solúvel em distúrbios inflamatórios e/ou autoimunes

Info

Publication number
BRPI0412243A
BRPI0412243A BRPI0412243-7A BRPI0412243A BRPI0412243A BR PI0412243 A BRPI0412243 A BR PI0412243A BR PI0412243 A BRPI0412243 A BR PI0412243A BR PI0412243 A BRPI0412243 A BR PI0412243A
Authority
BR
Brazil
Prior art keywords
inflammatory
soluble
autoimmune disorders
human
treatment
Prior art date
Application number
BRPI0412243-7A
Other languages
English (en)
Inventor
Yolande Chvatchko
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of BRPI0412243A publication Critical patent/BRPI0412243A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

"USO DE CD164 SOLúVEL EM DISTúRBIOS INFLAMATóRIOS E/OU AUTOIMUNES". A presente invenção refere-se a usos terapêuticos de proteínas solúveis compreendendo a região extracelular de CD164 humana, em particular para o tratamento de distúrbios inflamatórios e/ou autoimunes.
BRPI0412243-7A 2003-07-23 2004-07-23 uso de cd164 solúvel em distúrbios inflamatórios e/ou autoimunes BRPI0412243A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03077316 2003-07-23
PCT/EP2004/051596 WO2005011728A2 (en) 2003-07-23 2004-07-23 Use of soluble cd164 in inflammatory and/or autoimmune disorders

Publications (1)

Publication Number Publication Date
BRPI0412243A true BRPI0412243A (pt) 2006-09-19

Family

ID=34112463

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412243-7A BRPI0412243A (pt) 2003-07-23 2004-07-23 uso de cd164 solúvel em distúrbios inflamatórios e/ou autoimunes

Country Status (15)

Country Link
US (2) US20060257402A1 (pt)
EP (1) EP1646396A2 (pt)
JP (1) JP4705028B2 (pt)
KR (1) KR20060106810A (pt)
CN (1) CN1845752A (pt)
AR (1) AR045074A1 (pt)
AU (1) AU2004260835A1 (pt)
BR (1) BRPI0412243A (pt)
CA (1) CA2532870A1 (pt)
EA (1) EA009389B1 (pt)
IL (1) IL173197A0 (pt)
NO (1) NO20060781L (pt)
RS (1) RS20060023A (pt)
WO (1) WO2005011728A2 (pt)
ZA (1) ZA200600193B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803910B2 (en) 2005-01-24 2010-09-28 Merck Serono S.A. Soluble CD164 polypeptides
EA022609B1 (ru) 2007-02-12 2016-02-29 А1М Фарма Аб Применение свободного фетального гемоглобина в качестве маркера преэклампсии
CA2730531A1 (en) 2008-07-18 2010-01-21 A1M Pharma Ab Medical use of the radical scavenger and antioxidant alpha-1-microglobulin
US8392585B1 (en) * 2011-09-26 2013-03-05 Theranos, Inc. Methods and systems for facilitating network connectivity
WO2022099695A1 (en) * 2020-11-16 2022-05-19 Jiangsu Cell Tech Medical Research Institute Co., Ltd. Cd164 fusion and uses thereof
CN114891107A (zh) * 2022-05-12 2022-08-12 北京农学院 一种抗猪cd164l2单克隆抗体制备与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins
WO2002098917A2 (en) * 2001-02-12 2002-12-12 Curagen Corporation Human proteins and nucleic acids encoding same

Also Published As

Publication number Publication date
EA009389B1 (ru) 2007-12-28
CN1845752A (zh) 2006-10-11
ZA200600193B (en) 2007-04-25
WO2005011728A2 (en) 2005-02-10
AU2004260835A1 (en) 2005-02-10
RS20060023A (sr) 2008-06-05
AR045074A1 (es) 2005-10-12
US20060257402A1 (en) 2006-11-16
NO20060781L (no) 2006-03-17
IL173197A0 (en) 2006-06-11
US8075894B2 (en) 2011-12-13
JP4705028B2 (ja) 2011-06-22
US20090285838A1 (en) 2009-11-19
JP2006528159A (ja) 2006-12-14
KR20060106810A (ko) 2006-10-12
CA2532870A1 (en) 2005-02-10
EA200600314A1 (ru) 2006-06-30
WO2005011728A3 (en) 2005-06-02
EP1646396A2 (en) 2006-04-19

Similar Documents

Publication Publication Date Title
WO2003038043A3 (en) Combinations of dr5 antibody and other therapeutic agents
SI1957539T1 (sl) Humana monoklonska protitelesa proti protein tirozin kinazi 7 (PTK7) in njihova uporaba
BRPI0407662A (pt) derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas
BRPI0412411A (pt) tetrahidro-1h-pirazol[3,4-c]piridinas substituìdas, composições que as contêm e utilização
PT1446122E (pt) Utilizacao de flibanserina no tratamento de disturbios de desejo sexual
WO2006121610A3 (en) Personal care compositions and methods for their use
BR0314354A (pt) Formação para gentes lipofìlicos
BR0113798A (pt) Derivados de resorcinol
DE60237431D1 (de) Rezeptor-selektive cannabimimetische aminoalkylindole
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
CR7875A (es) Variantes de inmunoglobina y usos de esto
BR0008784A (pt) Usos
PL1615952T3 (pl) Sposoby leczenia chorób zapalnych z zastosowaniem środków specyficznie wiążących ludzką angiopoetynę-2
ECSP066297A (es) Anticuerpos contra interleucina 22 y usos de los mismos
DOP2002000429A (es) Imidazotriazinas
IL132293A0 (en) Use of lactoferin in the treatment of allergen induced disorders
BR0211978A (pt) Terapia de combinação para o tratamento de câncer
BRPI0407693A (pt) uso de esteróides para preparação de formulações utilizáveis no tratamento de pessoas sofrendo de distúrbios oculares, bem como formulação assim obtidos
BRPI0412243A (pt) uso de cd164 solúvel em distúrbios inflamatórios e/ou autoimunes
DE50009838D1 (de) Humanes antibiotisches protein
BR0011363A (pt) Quimera il6ril6 para o tratamento de doenças neurodegenerativas
BRPI0407742A (pt) uso de glicocorticóides para preparação de formulação utilizáveis no tratamento de angiogênese ocular patológica, bem como formulção assim obtida
IL171384A (en) Use of slurp-1 in the preparation of medicaments for the treatment of neurological disorders
BRPI0417146A (pt) combinações farmacêuticas
PT1687023E (pt) Uso de histonas específicas para o tratamento de doenças parasitárias

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: LABORATOIRES SERONO S.A. (CH)

Free format text: TRANSFERIDO DE: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.